Third Randomized Controlled Trial (RCT) of the Vesair™ Bladder Control System For the Treatment of Stress Urinary Incontinence Delivers Promising Results

Solace Therapeutics, Inc., today announced that data from a multicenter 221 patient randomized controlled trial has met study endpoints with statistical significance. Dr. Eric Rovner will be presenting a poster of the results from the SUCCESS Clinical Trial at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) meeting in Scottsdale, Arizona on Thursday, March, 2^nd. This is the Company’s third randomized controlled trial to evaluate the safety and efficacy of the Vesair Bladder Control System; a novel, office-based, reversible treatment designed to reduce or eliminate urine leakage in female patients with Stress Urinary Incontinence (SUI). Read more.

Source: Business Wire, March 1, 2017

NMC Urged to Tackle ‘Glaring Hole’ in Bowel and Bladder Education

A “glaring hole” in training that is failing to ensure nurses are taught bowel and bladder care is putting patients at risk, a group of MPs has warned. In a letter to the Nursing and Midwifery Council, the All Party Parliamentary Group for Continence Care urged the regulator to consider including such training in pre-registration education, as part of its current review of university standards. The group of MPs said it was a concern that it was not a core competency for nurses, considering that fact that more than 14 million adults in the UK had bladder control problems and 6.5 million have bowel control issues, and 900,000 children and young people have bladder and bowel dysfunction. Read more.

Source: Nursing Times, March 1, 2017

Pelvic Floor Symptoms May Lead To Exercise Avoidance in Menopausal Women

Physical activity improves health and may delay the onset of chronic diseases. For women in particular, the rate of some chronic diseases accelerates at middle age around the time of menopause; therefore it is important to identify the determinants of health-enhancing physical activity during midlife in this population. The main aim of this study was to characterize the level of physical activity and to examine the association between different female reproductive factors and objectively-measured physical activity in middle-aged women. The reproductive factors included cumulative reproductive history index, and perceived menopausal and pelvic floor dysfunction symptoms. Read more.

Source: MedicalResearch.com, Feburary 28, 2017

Hatch Medical to Broker Innovative Male Urinary Incontinence Device

Hatch Medical, L.L.C., a medical device incubator and technology brokerage firm, announced today that it has entered into an agreement with MUCOM, L.L.C. to broker the sale or license of its patented male urinary incontinence device MUI Comfort™. MUI Comfort™ is an integrated external collection system that meets the needs of a growing demographic that is coping with the consequences of stress, urge, and overflow incontinence. This innovative technology is differentiated from competing products by providing a complete solution that addresses both functional and psychological aspects associated with male urinary incontinence. Read more.

Source: Yahoo Finance! February 16, 2017

USC Viterbi Researcher’s Work Seeks to Help Those Who Really Have to Go

Tissue regeneration gets the attention of Eun Ji Chung, a USC researcher who also studies a common and distressing problem: bladder control. Chung, an assistant professor at the USC Viterbi School of Engineering, examines how tissue regeneration could help patients with urinary incontinence caused by the loss or weakened control of the muscle controlling the release of urine from the bladder. The problem affects millions, especially women and females who have given birth. She hopes to provide a solution by restoring urethral tissue form and function. The goal: to develop biocompatible and bioactive hydrogels that can release growth factors and stimulate muscle repair using adipocytes, or fat stem cells, for the urethra, she said. Read more.

Source: USC News, February 13, 2017

What You Need to Know to Put the Brakes on USI

Urinary stress incontinence (USI) affects 25 per cent of women over 40 with the incidence increasing with age. It’s defined as a loss of urine often with cough, sneeze, laughing, running or lifting. Yet despite the prevalence of this condition, many women do not seek help until symptoms become severe and have been ongoing for at least two years. Factors contributing to USI are childbirth, pregnancy, menopause, low back pain, weight gain and smoking. USI responds well to conservative non-surgical treatment with the first line of treatment often being pelvic floor strengthening exercises under the supervision of a physiotherapist. Physiotherapists often use biofeedback and electrical stimulation to help reeducate these muscles. Read more.

Source: The Chronicle Herald, February 8, 2017

Market Research Study on Underactive Bladder Seeking Participants

You are invited to participate in a paid market research study about your personal experience with underactive bladder (UAB), which may also be known as impaired bladder emptying, hypotonic/flaccid bladder, detrusor underactivity/failure, voiding dysfunction, or chronic/acute urinary retention. The market research firm conducting the study would like to understand more about your personal journey and discuss potential new diagnostic and treatment options. In order to participate, you must have been diagnosed with UAB. The study consists of a 45-minute phone interview that will require internet access, and you will be compensated $100 for your time. If you are interested in participating, please click this link to see if you qualify: https://hub.m3globalresearch.com/page/r13650tdip.cfm This study is being managed by ZS, an Independent Research Firm, in compliance with marketing research standards. The study concludes on February 8, 2017.

Revolutionary Skin Protectant Finally Gives Nurses the Power to Stop, Reverse and Prevent Incontinence Associated Dermatitis

As our aging population grows, nurses are continuing to see more instances of tough-to-manage skin breakdown due to incontinence. Skin damage associated with urine and/or fecal exposure, otherwise known as incontinence associated dermatitis (IAD), is a resource-intensive condition that can be very painful for patients. To help combat this debilitating problem, 3M introduces its revolutionary 3M™ Cavilon™ Advanced Skin Protectant, a high endurance skin protectant designed to stop, reverse and prevent the damaging effects of moderate to severe IAD. The new skin protectant provides clinicians with an easier, more effective way to manage patients with IAD to help improve their quality of life and overall patient experience. Read more.

Source: Business Wire, February 1, 2017

AUA, Urology Care Foundation Applaud Introduction Of Resolution Supporting November As “National Bladder Health Month”

The American Urological Association (AUA) and the Urology Care Foundation, together with the Bladder Health Alliance – a coalition of groups representing physicians, patients and veterans – applauded Congressman Eliot Engel (NY-16) for his introduction of House Resolution 67, a measure supporting the designation of November 2017 as “National Bladder Health Month.” Read more.

Source: PRNewswire, January 30, 2017

Drug May Be New Weapon Against a ‘Superbug’

A newly approved drug may help in the battle against Clostridium difficile — a potentially fatal “superbug” gut infection that has become a scourge in U.S. hospitals. In two clinical trials, researchers found that the drug, called bezlotoxumab (Zinplava), cut the risk of a recurrent C. difficile infection by almost 40 percent. That’s important, because the gut infection commonly comes back after treatment with antibiotics — around 20 percent of the time, according to the U.S. Centers for Disease Control and Prevention. Read more.

HealthDay News, January 25, 2017